Welcome to Somaxon Pharmaceuticals

Somaxon Pharmaceuticals is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon is publicly traded on the NASDAQ Stock Market under the symbol “SOMX”.

Latest News

June 4, 2009
SOMAXON RESUBMITS NEW DRUG APPLICATION FOR SILENOR® (DOXEPIN) FOR THE TREATMENT OF INSOMNIA (.pdf)

Join Our Mailing List

Please join our mailing list if you wish to receive news regarding Somaxon and its products.